• Bengaluru
  • 19 July 2016
  • Views
  • By Kanchana TK

Protect and Encourage Innovation

Guest article by Kanchana TK, Director General, Organisation of Pharmaceutical Producers of India (OPPI) on New IPR Policy


Kanchana TK, Director General, OPPI

‘Creativity is thinking up new things. Innovation is doing new things'... said Theodore Levitt, an American economist and professor at Harvard Business School. So when innovations happen, one way to encourage them is by rewarding it. Patents are important to protect innovation. It provides the innovator with legal means to prevent others from replicating the same innovation, albeit, without the original intellectual as well as financial inputs.

The recently announced National IPR Policy by the Government of India is a welcome step. The policy shows intent of the government to respect all forms of intellectual property and foster a culture of innovation. The policy will be a boon for all industries where Intellectual Property including patents is the bloodline. Industries benefitting from a robust IPR policy include Start-ups, IT, and Bio-Pharmaceuticals among others.

A significant initiative that the policy highlights is the inclusion of IPR as part of academic curriculum in educational institutes. This will address two important issues: Firstly, it will help the younger generation understand the value of creating an eco-system which respects innovation. Creating awareness on the importance of innovation among the young minds will help improve the existing practices. Second, while there are multiple applications for patents, very few are actually processed till its final stage. An education and awareness initiative will help generate better understanding about applications and protection of innovation. As Indian companies begin to invest heavily in R&D and start operating in multiple geographies, an awareness of safeguarding innovations becomes critical.

Though the policy provides clear direction towards an innovation- driven approach, it falls short in the area of how precisely it can safeguard these innovations. One of the apparent shortfalls of the policy is that while one of its previous draft recognised the need for patent cases to be adjudicated expeditiously, the final one does not cover the earlier recommendation of specialised benches in the High Courts of Bombay, Calcutta, Delhi and Madras, neither does it suggest designated district level IP courts.

The research-based pharmaceutical industry is driven by innovation and therefore depends on patents and other intellectual property rights. Hopefully, the policy will lead to an interpretation of the Indian Patent Act that respects innovation, encourages research and facilitates effective enforcement mechanisms.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email